Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
Perthera, an industry leader in precision oncology decision support, recently announced that Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, joined Perthera as Chief Medical Officer. Dr. Raghavan is founding President of the Levine Cancer Institute and former Chair and Director of the Cleveland Clinic Taussig Cancer Institute.
At Perthera, Dr. Raghavan will help guide the current implementation of the Perthera Report, participate in the group’s unique virtual molecular tumor board, and advise on new product development. He will also engage with community and academic oncologists to ensure the company’s unique products and services continue to expand and deliver on the ever-growing and complex precision oncology needs of practicing clinicians.
Emanuel “Chip” Petricoin, PhD
“I look forward to helping Perthera reach the full potential of [its] best-in-class AI-based treatment decision support tool, the Perthera Report, and am especially excited to see the recent issuance of a CPT code that covers Perthera’s unique and patented product. Together, we will continue the push to help oncologists make more informed decisions, ultimately improving outcomes for their patients,” Dr. Raghavan said.
Emanuel “Chip” Petricoin, PhD, Chief Science Officer and cofounder of Perthera, commented: “[Dr. Raghavan’s] scientific and clinical expertise as well as previous experience leading academic and community cancer centers will be essential to grow our scientific research-oriented products and services.”
Professional Experience
Dr. Raghavan has held numerous senior appointments, including Chair of the National Cancer Institute Clinical Investigations Review Committee, Chair of the Veterans Administration Merit Review Board in Oncology, and member of the U.S. Food and Drug Administration Oncology Drug Advisory Committee. He has advised multiple cancer institutes and international cancer research organizations, contributing his expertise to shape the future of cancer care and research globally. Dr. Raghavan also holds the title of Emeritus Professor of Medicine at Wake Forest School of Medicine. He continues to serve as a volunteer oncologist at the Veterans Administration Health Care Center in Charlotte, North Carolina.
In addition, Dr. Raghavan has contributed more than 300 scientific papers and a dozen textbooks to the field of oncology. He has been on the editorial boards of many scientific journals.
